Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

August 06, 2025 23:24 ET | Source: Sana Biotechnology, Inc

Sana Biotechnology Announces Pricing of Public Offering

SEATTLE, Aug. 06, 2025 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (Nasdaq: SANA) (“Sana”), a company focused on changing the possible for patients through engineered cells, today announced that it...
August 06, 2025 16:38 ET | Source: Sana Biotechnology, Inc

Sana Biotechnology Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants

SEATTLE, Aug. 06, 2025 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (Nasdaq: SANA) (“Sana”), a company focused on changing the possible for patients through engineered cells, today announced that it...
July 24, 2025 21:37 ET | Source: ADT Inc.

ADT Announces Pricing of Secondary Public Offering of Common Stock and Concurrent Share Repurchase

ADT Inc. (NYSE: ADT) today announced the pricing of the previously announced secondary public offering of 71,000,000 shares of the Company’s common stock.
July 24, 2025 20:45 ET | Source: Absci Corporation

Absci Announces Pricing of Public Offering of Common Stock

VANCOUVER, Wash., July 24, 2025 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI) (“Absci”), a clinical-stage biopharmaceutical company advancing potential breakthrough therapeutics designed with...
July 24, 2025 16:54 ET | Source: Absci Corporation

Absci Announces Proposed Public Offering of Common Stock

VANCOUVER, Wash., July 24, 2025 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI) (“Absci”), a clinical-stage biopharmaceutical company advancing potential breakthrough therapeutics designed with...
June 30, 2025 21:45 ET | Source: Dyne Therapeutics, Inc.

Dyne Therapeutics Announces Pricing of $200.0 Million Public Offering of Common Stock

WALTHAM, Mass., June 30, 2025 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage company focused on delivering functional improvement for people living with genetically...
June 30, 2025 09:10 ET | Source: Kanzhun Limited

KANZHUN LIMITED Announces Pricing of Share Offer

BEIJING, June 30, 2025 (GLOBE NEWSWIRE) -- KANZHUN LIMITED (“BOSS Zhipin” or the “Company”) (Nasdaq: BZ; HKEX: 2076), a leading online recruitment platform in China, today announced the pricing of...
June 26, 2025 23:56 ET | Source: Kymera Therapeutics, Inc.

Kymera Therapeutics Announces Pricing of $250 Million Public Offering

WATERTOWN, Mass., June 26, 2025 (GLOBE NEWSWIRE) -- Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing a new class of oral small molecule degrader...
June 25, 2025 16:05 ET | Source: Kymera Therapeutics, Inc.

Kymera Therapeutics Announces Proposed Public Offering

WATERTOWN, Mass., June 25, 2025 (GLOBE NEWSWIRE) -- Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing a new class of oral small molecule degrader...
June 10, 2025 21:59 ET | Source: BrightSpring Health Services, Inc.

BrightSpring Announces Pricing of Secondary Offering of Common Stock

LOUISVILLE, Ky., June 10, 2025 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. (NASDAQ: BTSG) (“BrightSpring” or the “Company”), a leading provider of home and community-based health services...